[1]
M. Babczyńska, A. Buliszak, P. Marcjasz, A. Bioły, A. Borończyk, and P. Zając, “Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy”, Qual Sport, vol. 41, p. 59986, May 2025.